Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer (ARIEL3)

Clinical trial NCT01968213 · COMPLETED

Trial details

NCT number: NCT01968213
Sponsor: pharmaand GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancer Peritoneal Cancer

Start date: 2014-04-07
Primary completion: 2017-04-01
Enrollment: 564

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.